(1) Department of Colorectal Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;(2) Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA;
Abstract:
Background
Neoadjuvant chemoradiation followed by surgery and adjuvant chemotherapy is typically recommended for patients with locally advanced rectal cancer. Patients with pathologically node-negative tumors have an improved prognosis, but recurrence patterns and independent prognostic factors in these patients have been incompletely characterized.